Literature DB >> 19821573

Molecular proteomics imaging of tumor interfaces by mass spectrometry.

Suki Kang1, Hyo Sup Shim, Jong Sik Lee, Dong Su Kim, Hak Yong Kim, Seong Hyun Hong, Pan Soo Kim, Joo Heon Yoon, Nam Hoon Cho.   

Abstract

The specific molecular profiles of ovarian cancer interface zones (IZ), the region between tumors and normal tissues, were evaluated using a new method involving matrix-assisted laser desorption/ionization (MALDI)-imaging mass spectrometry (IMS). We analyzed three ovarian serous carcinomas using MALDI-IMS. Principal component analysis (PCA) was used to evaluate the quality of tissue spatial features based on MALDI-IMS, and for analysis of large data sets of MALDI-IMS. Two-dimensional gel electrophoresis and fluorescence microscopy were used to verify interface-specific proteins. Unique profiles were identified for the tumors, the normal zone, and the IZ. Through MALDI analysis, two interface-specific proteins, plastin 2 and peroxiredoxin 1 (PRDX 1), were identified as differentially regulated between zones. Fluorescence microscopy revealed high expression levels of plastin 2 and PRDX 1 along the IZ of ovarian tumors. This comparative proteomics study using tissue MALDI-IMS suggested that the IZ is different from the adjacent tumor and normal zones, and that plastin 2 and PRDX 1 may be interface markers specific to ovarian tumors.

Entities:  

Mesh:

Year:  2010        PMID: 19821573     DOI: 10.1021/pr900666q

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  22 in total

1.  High speed data processing for imaging MS-based molecular histology using graphical processing units.

Authors:  Emrys A Jones; René J M van Zeijl; Per E Andrén; André M Deelder; Lex Wolters; Liam A McDonnell
Journal:  J Am Soc Mass Spectrom       Date:  2012-02-04       Impact factor: 3.109

2.  Imaging mass spectrometry data reduction: automated feature identification and extraction.

Authors:  Liam A McDonnell; Alexandra van Remoortere; Nico de Velde; René J M van Zeijl; André M Deelder
Journal:  J Am Soc Mass Spectrom       Date:  2010-08-21       Impact factor: 3.109

Review 3.  Molecular imaging by mass spectrometry--looking beyond classical histology.

Authors:  Kristina Schwamborn; Richard M Caprioli
Journal:  Nat Rev Cancer       Date:  2010-08-19       Impact factor: 60.716

Review 4.  Mass spectrometric imaging for biomedical tissue analysis.

Authors:  Kamila Chughtai; Ron M A Heeren
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

Review 5.  Molecular mass spectrometry imaging in biomedical and life science research.

Authors:  Jaroslav Pól; Martin Strohalm; Vladimír Havlíček; Michael Volný
Journal:  Histochem Cell Biol       Date:  2010-10-28       Impact factor: 4.304

6.  Considerations for quantification of lipids in nerve tissue using matrix-assisted laser desorption/ionization mass spectrometric imaging.

Authors:  Rachelle R Landgraf; Timothy J Garrett; Maria C Prieto Conaway; Nigel A Calcutt; Peter W Stacpoole; Richard A Yost
Journal:  Rapid Commun Mass Spectrom       Date:  2011-10-30       Impact factor: 2.419

Review 7.  MALDI imaging mass spectrometry for direct tissue analysis: technological advancements and recent applications.

Authors:  Benjamin Balluff; Cedrik Schöne; Heinz Höfler; Axel Walch
Journal:  Histochem Cell Biol       Date:  2011-07-30       Impact factor: 4.304

Review 8.  MALDI imaging mass spectrometry--painting molecular pictures.

Authors:  Kristina Schwamborn; Richard M Caprioli
Journal:  Mol Oncol       Date:  2010-09-25       Impact factor: 6.603

Review 9.  Recent advances in single-cell MALDI mass spectrometry imaging and potential clinical impact.

Authors:  Kristin J Boggio; Emmanuel Obasuyi; Ken Sugino; Sacha B Nelson; Nathalie Yr Agar; Jeffrey N Agar
Journal:  Expert Rev Proteomics       Date:  2011-10       Impact factor: 3.940

Review 10.  MALDI Imaging Mass Spectrometry (MALDI-IMS)-application of spatial proteomics for ovarian cancer classification and diagnosis.

Authors:  Johan O R Gustafsson; Martin K Oehler; Andrew Ruszkiewicz; Shaun R McColl; Peter Hoffmann
Journal:  Int J Mol Sci       Date:  2011-01-21       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.